Sponsor pipeline

Stemline Therapeutics, Inc. clinical trial pipeline

Get alerts when Stemline Therapeutics, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-14 NCT07873827 KATALYST-HEME-01: Study of the KAT6 Inhibitor MEN2312 in Heme Malignancies Phase 1/2 Not Yet Recruiting

Active trials by phase

Phase 1
2
Phase 1/2
3
Phase 2
3
Phase 3
1
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Breast Cancer (6) · Leukemia (4) · Acute Myeloid Leukemia (AML) (2) · Ovarian Cancer (1)

Get alerts when Stemline Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free